http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (HealthDay)—Even within an integrated Veterans Affairs (VA) system with a uniform national formulary and established criteria for drug use, there is substantial variation in the use of thiazolidinediones and long-acting insulin analogues among veterans with type 2 diabetes mellitus (T2DM), according to a research letter published online Oct. 8 in the Archives of Internal Medicine. http://medicalxpress.com/news/2012-10-costly-diabetes-medications-varies-widely.html Diabetes Fri, 12 Oct 2012 11:00:04 EST news269256871 Building on previous work with the botanical abscisic acida, researchers in the Nutritional Immunology and Molecular Medicine Laboratory (NIMML) have discovered that abscisic acid has anti-inflammatory effects in the lungs as well as in the gut. The results will be published in the Journal of Nutritional Biochemistry. http://medicalxpress.com/news/2012-07-botanical-compound-crucial-influenza.html Medical research Wed, 18 Jul 2012 15:18:48 EST news261843492 An increased risk of bladder cancer is linked to the use of pioglitazone, a medication commonly used to treat type 2 diabetes, according to a new study published in CMAJ (Canadian Medical Association Journal). http://medicalxpress.com/news/2012-07-diabetes-drugs-bladder-cancer.html Cancer Tue, 03 Jul 2012 12:00:01 EST news260534741 Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year follow-up evaluations, according to a report published Online First by Archives of Internal Medicine. http://medicalxpress.com/news/2012-06-thiazolidinedione-patients-diabetes-diabetic-macular.html Diabetes Mon, 11 Jun 2012 16:01:45 EST news258649293 (HealthDay) -- Thiazolidinediones are associated with a lower risk of liver and colorectal cancer in patients with type 2 diabetes, according to a study published in the May issue of Hepatology. http://medicalxpress.com/news/2012-04-thiazolidinediones-tied-cancer-diabetes-patients.html Cancer Fri, 27 Apr 2012 08:40:01 EST news254720415 For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone (trade name Avandia) has been in the spotlight for its possible link to increased cardiovascular events, but it also seems to come with unexplained vascular benefits and an unwelcome tendency for weight gain. Now, two separate studies in the July Cell Metabolism, a Cell Press publication, explore those other effects of the drugs known collectively as thiazolidinediones (TZDs), both of which stem from their activity in fat. http://medicalxpress.com/news/2011-07-diabetes-drug-side-effects-fat.html Medical research Tue, 05 Jul 2011 12:29:26 EST news229087751 Drugs known as thiazolidinediones, or TZDs for short, are widely used in diabetes treatment, but they come with a downside. The drugs have effects on the kidneys that lead to fluid retention as the volume of plasma in the bloodstream expands. http://medicalxpress.com/news/2011-05-popular-diabetes-drugs-cardiovascular-side_1.html Medical research Tue, 03 May 2011 12:17:37 EST news223643824